Chimerix reported 148.14M in Current Assets for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Ardelyx ARDX:US $ 205.38M 10.69M
Chimerix CMRX:US 148.14M 66.48M
Curis CRIS:US $ 161.86M 10.89M
Dynavax Technologies DVAX:US $ 427.53M 137.52M
Emergent Biosolutions EBS:US $ 1162.1M 19M
Epizyme EPZM:US $ 340.42M 64.68M
Gilead Sciences GILD:US $ 14498M 1220M
Glaxosmithkline GSK:US $ 17566M 958M
Life Technologies LIFE:US $ 52.13M 16.6M
Mirati Therapeutics MRTX:US $ 1303.51M 100.13M
Novavax NVAX:US $ 2246.78M 998.58M
Xoma XOMA:US $ 70.25M 17.82M